TEM·Tempus AI, Inc.

TEM's 15-session tracking closes at -12.76% from the $67.88 reference. The path reached +7.87% at best and -14.22% at worst. Fresh closure evidence records a $59.01 provider price (-13.07% versus the reference) and a $59.05 post-market quote (+0.07% versus the regular close). Current session-average price, RSI, EMA trend and 52-week position readings are unavailable; traded volume is 0.57 times average. The confirmed Tempus issuer release remains company context, not proof it caused or sustained the return. The continuation condition failed, so public tracking ends.

TEM's tracked loss widened 0.39 points to -13.16% since the previous public note. The stock fell 4.14% to USD 58.74, finished 0.66% below VWAP on 0.85 times average volume with no confirmed structure; Healthcare-relative strength over twenty sessions remains positive, but the event-linked continuation thesis still lacks current price support.

TEM's tracked loss widened 1.50 points to -12.77% since the previous public note. The latest capture fell 3.66% to USD 59.04, below VWAP by 0.66% in the lower third of its range on 0.69 times average volume; Healthcare-relative strength remains positive over twenty sessions, but the event-linked continuation thesis has no confirmed structure or current price support.

TEM's tracked loss widened 1.87 points to -11.27% since the last public note. The latest capture slipped 1.75% to .21, although price sat 1.61% above VWAP near the top of its range; participation was only 0.24 times average and decelerating, with no confirmed structure. Older Healthcare-relative strength keeps the event case relevant, but the stated continuation condition remains unproven.

TEM's tracked loss edged from -9.49% to -9.40% since the last public note, but the latest capture fell 4.68% to .28, below VWAP near the bottom of its range on 1.13x average volume. The event-linked mechanism remains specific, yet the failed hold and absent structure leave continuation without current price support.

TEM's tracked loss widened 1.51 points to -9.49% as the latest capture fell 4.90% to USD 61.14, 2.20% below VWAP on 0.71x average volume. Its 20-session lead over Healthcare remains 10.71 points, but decelerating participation and no confirmed structure leave the event-driven continuation thesis without a short-term hold.

TEM's tracked loss widened 3.03 points to -7.98% as the latest capture fell 2.68% to USD 62.57, 0.89% below VWAP on just 0.22x average volume, with no confirmed structure. The event-linked case remains relevant because TEM is still up 12.37% over 20 sessions while Healthcare is down 0.85%, but that older relative strength cannot repair the failed short-term hold; the continuation thesis remains unconfirmed.

TEM's tracked loss widened 0.40 points to -4.95% as price fell 0.51% to $64.29, moved 0.75% below VWAP and traded at 0.80x average volume. Strong 20-session performance versus Healthcare keeps the event-driven case relevant, but the stated VWAP condition is no longer holding and no durable demand is confirmed.

TEM's tracked loss widened 0.50 points to -4.55% as price fell 0.50% to $64.30 and moved 0.76% below VWAP. Healthcare-relative performance remains strong (+17.40 points over 20 sessions), but decelerating activity, 0.62x volume and no confirmed structure mean the event-driven repair is no longer holding the stated VWAP condition.

TEM tracked loss narrowed 0.41 points to -4.05% at session 12 as the latest capture rose 0.39% to $64.87 and moved 0.39% above VWAP. Healthcare-relative performance remains +18.01 points over 20 sessions, but volume is 0.15 times average and no structure is confirmed, so the event-driven repair is holding better without yet showing durable demand.

TEM tracked loss narrowed 0.30 points to -4.46% as the latest capture was nearly flat at $64.62, only 0.12% below VWAP on 0.70 times average volume. Healthcare-relative strength remains a real support for the event-driven case, but the lack of confirmed structure and light participation leave the earlier repair unproven.

TEM tracked loss widened 0.18 points to -4.76% as the latest capture slipped 0.34% to $64.44 and moved 0.40% below VWAP. Healthcare-relative strength keeps the event-driven case visible, but volume is 0.54 times average, no confirmed structure is recorded and the earlier repair has not yet shown a durable hold.

TEM's tracked loss improved 0.55 points to -4.58% as the latest capture slipped 0.32% to $64.46 and moved just below VWAP at the lower-middle of its range on 0.18 times average volume. Strong twenty-session Healthcare-relative performance keeps the event-driven case visible, but the loss of the intraday reference on light participation means the earlier repair is not yet durable.

TEM's tracked loss narrowed 2.06 points to -5.13% as the latest capture rose 4.29% to $64.60 and moved 2.3% above VWAP near the top of its range. That is a meaningful price repair, but only 0.59 times average volume and no confirmed structure leave the event-driven continuation thesis conditional: the tape has recovered part of the move, not yet demonstrated durable demand.

TEM's tracked loss improved 1.24 points to -7.19% in the latest capture, with price up 0.79% to 62.43 and above VWAP at 41.8% of the range on only 0.15 times average volume. The event-driven repricing case retains strong Healthcare-relative performance and a modest price repair, but participation is decelerating and structure is unconfirmed; continuation remains unproven.

TEM's tracked result fell 2.57 points to -8.43% after the latest capture slipped 0.53% to $61.94. The event-driven case remains a plausible explanation, and long-window Healthcare-relative strength still supports attention, but price is 2.01% below VWAP in the lower part of its range on 0.87 times average volume with no confirmed structure; the continuation condition has failed again.

TEM tracked loss improved 2.08 points to -5.86% after the latest capture rose 3.15% to 64.23. Accumulation and a 31.86-point Healthcare-relative excess support a repair attempt, but price remains 1.22% below VWAP in the lower part of its range on 0.34 times average volume, with no confirmed structure.

TEM's tracked loss remains -7.94% as the latest capture fell 1.24% to $62.27. Price is 1.25% below VWAP in the lower third of its range on 0.93x average volume; accumulation and strong Healthcare-relative performance help, but fading participation and no confirmed structure leave the event-repricing case conditional.

TEM's tracked loss widened 1.16 points to -7.21% even as the current capture slipped 0.49%. Price is 0.53% below VWAP in the lower-middle part of its range on 0.76x average volume; accumulation and supportive Healthcare context remain constructive, but decelerating participation and no confirmed structure keep the event-repricing case conditional.

TEM's tracked loss narrowed 0.74 points to -6.05% as the current capture rose 1.25%, but price sat 0.34% below VWAP near mid-range on 0.26x average volume. Accumulation and supportive Healthcare context help the event-repricing case, yet decelerating participation and no confirmed structure keep continuation conditional.

TEM improved by 0.11 points to -6.79% and held 0.44% above VWAP with 1.07x average volume; flow registered accumulation and Healthcare remains supportive. The event repricing is stabilizing, but no confirmed structure means the continuation case still depends on holding this reference with follow-through.

TEM recovered 1.41 points to -6.68%, with price back 0.67% above VWAP and in the middle-upper part of the range. Healthcare relative performance and accumulation support the longer case, but participation is fading at 0.80x average volume and no confirmed structure has formed, so the event-driven continuation thesis remains unresolved.

TEM fell to -8.09% after a 4.06% decline to 61.44, just below VWAP on 0.23x average volume. Strong longer-window Healthcare performance cannot repair the broken short-term hold, so the event case remains unresolved.

TEM tracked result fell 6.36 points to -5.32% as the current capture dropped 9.41% to 64.04 on 1.31x average volume, with no fresh VWAP reading. The 20-session return remains strong at +59.61% versus +4.93% for Healthcare, but that long-window advantage cannot repair the broken short-term hold; the event case remains context while follow-through is unresolved.

TEM’s tracked result fell 3.47 points to +1.04% as the early capture declined 3.14%, moved 1.15% below VWAP and held only 0.21x average volume. The event-driven thesis remains intact as context, but the price hold and participation condition that supported the repair have failed again.

TEM's tracked result improved 0.56 points to +4.51% as price gained 3.23% to 70.69, 0.77% above VWAP. Accumulation and the held average-price test support the event-driven case, but decelerating flow and a 2.33-ATR extension keep this a repair under observation rather than confirmed continuation.

TEM's tracked result improved 1.38 points to +3.95%, and the current capture is up 2.88% at 70.45, 0.36% above VWAP. The event-driven case still has price support, but volume is only 0.78 times average, participation is decelerating and the move remains 2.28 ATR above its reference; this is a held repair, not confirmed follow-through.

TEM's tracked result improved 1.33 points to +2.57%, and today's capture rose 1.30% while holding 0.70% above VWAP at 68.89. Strong Healthcare-relative performance keeps the event-driven case specific, but decelerating participation leaves this as repair rather than confirmation.

TEM's tracked result fell 0.36 points to +1.24% as the latest capture slipped 0.36% and moved 0.26% below VWAP in the lower half of its range. Accumulation and a 60.42-point Healthcare edge keep the event-driven thesis specific, but 0.77 times average participation, decelerating flow and no confirmed structure make this repair rather than confirmation.

TEM's tracked result improved 0.48 points to +1.60% as the latest capture gained 0.20% and held above VWAP mid-range. Strong healthcare-relative performance keeps the event-driven thesis specific, but participation is only 0.35 times average with fading flow, so the move remains a repair rather than confirmation.

TEM gave back 0.49 percentage points to a tracked result of +1.12% as the current capture slipped 0.59% below VWAP by 0.72% on 0.17 times average volume. Accumulation and 59.52 points of Healthcare-relative performance keep the event-driven thesis specific, but RSI at 72.79, a 2.02-ATR extension and fading flow leave the move in repair rather than confirmation.

TEM improved its tracked result by 0.71 points as the latest capture gained 3.87% and held 0.52% above VWAP on 1.32 times average volume. Healthcare strength and accumulation support the event-driven thesis, but RSI at 72.53 and a 2.33-ATR extension keep the move in repair rather than confirmation until demand defends the reference.

TEM tracked result improved 0.46 points to +0.90% as the stock gained 3.6% and held 0.29% above the session average, but participation was 1.08 times its three-month average and the move remains 2.3 ATR above its reference. Healthcare strength and accumulation keep the event-driven thesis alive; this is repair, not confirmation, until demand holds above the average price.

TEM's tracked result improved 2.61 points to +0.44% after a 3.39% gain that reclaimed the session average by 2.46% near the top of its range. Healthcare-relative strength and accumulation support the event-driven read, but participation is decelerating at 0.39x, RSI is 72.35 and the move is 2.35 ATR extended, leaving the hold vulnerable. The catalyst is visible; durable follow-through is not yet established.

TEM's tracked result fell 3.2 points to -2.17% after the current capture dropped 8.97% on 1.55x volume and finished 2.73% below VWAP near the bottom of its range. Healthcare-relative strength and the event mechanism remain visible, but continuation has lost its price hold again; the catalyst survives while the follow-through case remains unresolved.

TEM tracked result fell 5.93 points since the last panel note to +1.03%. The current capture dropped 6.43% on 0.49x volume and finished 2.04% below the session average near the lower range; strong healthcare-relative performance keeps the event explanation visible, but continuation has lost its price hold.

TEM's latest capture rose 9.06% and lifted the tracked result to +6.96%, with price 3.03% above the session average and participation at 2.47x the three-month average. Strong healthcare-relative performance and positive money flow support the event-driven continuation thesis, but RSI at 82.36 and a price near the top of its range make that support conditional rather than confirmed.

TEM tracked result improved 6.04 points to +6.96%, with price 2.33% above the session average and participation still at 2.07x. The event-driven continuation thesis remains supported by the structure and strong healthcare outperformance, but RSI at 82.03 and decelerating participation make that support conditional rather than confirmed.

TEM's first tracked result is +0.92% after a 2.38-point improvement; current price rose 1.94%, held 1.28% above the session average and sat in the upper range, but volume was 0.39x and decelerating. Healthcare outperformance of 52.31 points keeps the catalyst visible, yet first-observation uncertainty and fading participation leave continuation conditional.

TEM's first tracked result is -1.46%; the current capture rose 8.82% on 3.23x volume with accumulation and 38.08 points of healthcare outperformance. Price remains 0.17% above the session average and participation is accelerating, but an RSI of 80.54 and the first observation leave event-driven continuation conditional on holding that level.

TEM's first public capture rose 8.42% on 2.80x volume, with accumulation and a 37.26-point healthcare excess supporting the event-driven repricing. It remains conditional because price is 0.22% below the session average traded price, participation is decelerating, and the first observation has not shown whether buyers can hold that level.